Virology and Bacteriology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology), By End User (Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks), By Region and Competition, 2020-2030F

November 2025 | 183 pages | ID: V713C67338A8EN
TechSci Research

Abstracts

The Global Virology and Bacteriology Market, valued at USD 2.73 Billion in 2024, is projected to experience a CAGR of 6.70% to reach USD 4.03 Billion by 2030. The Global Virology and Bacteriology Market encompasses products and services dedicated to understanding, diagnosing, preventing, and treating viral and bacterial infections, including diagnostic assays, vaccines, and therapeutic solutions. Market growth is principally driven by the increasing global prevalence of infectious diseases, substantial advancements in molecular diagnostics, and the persistent threat of antimicrobial resistance.

Key Market Drivers

The global virology and bacteriology market is significantly influenced by the rising prevalence of infectious diseases, which creates an urgent demand for advanced diagnostic and therapeutic solutions. The continuous emergence and resurgence of pathogens, such as *Mycobacterium tuberculosis*, necessitate sustained public health and clinical intervention efforts. According to the World Health Organization, in November 2024, the Global Tuberculosis Report 2024 highlighted that approximately 8.2 million people were newly diagnosed with tuberculosis globally in 2023, an increase from 7.5 million in 2022, placing it as the leading infectious disease killer. This persistent burden drives the need for novel antimicrobials, efficient vaccines, and rapid diagnostic tools to detect infections and manage outbreaks, stimulating market expansion.

Key Market Challenges

A significant challenging factor impacting the Global Virology and Bacteriology Market is the substantial investment required for developing and commercializing novel antimicrobial agents and advanced diagnostic platforms. This financial barrier directly impedes the ability of companies to allocate sufficient resources towards exploratory research and late-stage clinical trials for new products. The development of innovative solutions, particularly for emerging pathogens and drug-resistant strains, necessitates prolonged research cycles and complex testing, significantly escalating overall expenditure. Such high investment costs can deter smaller companies and limit the portfolio expansion of larger entities, consequently slowing the introduction of much-needed advancements into the market.

Key Market Trends

Artificial Intelligence and Machine Learning are significantly reshaping the global virology and bacteriology market, accelerating drug discovery and enhancing diagnostic precision. These technologies facilitate rapid analysis of vast biological datasets, optimizing therapeutic target identification and drug candidate selection. According to AdvaMed, the medical technology association, a February 2024 report highlighted that over 80% of in-market medical technology products utilizing AI and machine learning perform diagnostic functions, demonstrating their critical role. This integration notably streamlines development timelines and reduces costs. For instance, in October 2025, Insilico Medicine advanced its AI-generated drug, Rentosertib, into Phase IIa clinical trials, underscoring AI's direct impact on novel therapy development.

Key Market Players

• Fujirebio Diagnostics Inc.
• Cepheid Inc.
• DiaSorin S.p.A.
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Scienion GmbH
• Grifols S.A.
• Qiagen N.V.
• Eiken Chemical Co. Ltd.
• Laboratory Corporation of America Holdings

Report Scope:

In this report, the Global Virology and Bacteriology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Virology and Bacteriology Market, By Technology:
• Molecular Diagnostics
• Immunoassays
• Diagnostic Imaging
• Information Technology
• Virology and Bacteriology Market, By End User:
• Hospitals
• Diagnostic Centers
• Research Laboratories
• Blood Banks
• Virology and Bacteriology Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Virology and Bacteriology Market.

Available Customizations:

Global Virology and Bacteriology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology)
  5.2.2. By End User (Hospitals, Diagnostic Centers, Research Laboratories, Blood Banks)
  5.2.3. By Region
  5.2.4. By Company (2024)
5.3. Market Map

6. NORTH AMERICA VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Technology
  6.2.2. By End User
  6.2.3. By Country
6.3. North America: Country Analysis
  6.3.1. United States Virology and Bacteriology Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Technology
      6.3.1.2.2. By End User
  6.3.2. Canada Virology and Bacteriology Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Technology
      6.3.2.2.2. By End User
  6.3.3. Mexico Virology and Bacteriology Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Technology
      6.3.3.2.2. By End User

7. EUROPE VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Technology
  7.2.2. By End User
  7.2.3. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Virology and Bacteriology Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Technology
      7.3.1.2.2. By End User
  7.3.2. France Virology and Bacteriology Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Technology
      7.3.2.2.2. By End User
  7.3.3. United Kingdom Virology and Bacteriology Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Technology
      7.3.3.2.2. By End User
  7.3.4. Italy Virology and Bacteriology Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Technology
      7.3.4.2.2. By End User
  7.3.5. Spain Virology and Bacteriology Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Technology
      7.3.5.2.2. By End User

8. ASIA PACIFIC VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Technology
  8.2.2. By End User
  8.2.3. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Virology and Bacteriology Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Technology
      8.3.1.2.2. By End User
  8.3.2. India Virology and Bacteriology Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Technology
      8.3.2.2.2. By End User
  8.3.3. Japan Virology and Bacteriology Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Technology
      8.3.3.2.2. By End User
  8.3.4. South Korea Virology and Bacteriology Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Technology
      8.3.4.2.2. By End User
  8.3.5. Australia Virology and Bacteriology Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Technology
      8.3.5.2.2. By End User

9. MIDDLE EAST & AFRICA VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Technology
  9.2.2. By End User
  9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Virology and Bacteriology Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Technology
      9.3.1.2.2. By End User
  9.3.2. UAE Virology and Bacteriology Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Technology
      9.3.2.2.2. By End User
  9.3.3. South Africa Virology and Bacteriology Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Technology
      9.3.3.2.2. By End User

10. SOUTH AMERICA VIROLOGY AND BACTERIOLOGY MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Technology
  10.2.2. By End User
  10.2.3. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Virology and Bacteriology Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Technology
      10.3.1.2.2. By End User
  10.3.2. Colombia Virology and Bacteriology Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Technology
      10.3.2.2.2. By End User
  10.3.3. Argentina Virology and Bacteriology Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Technology
      10.3.3.2.2. By End User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL VIROLOGY AND BACTERIOLOGY MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Fujirebio Diagnostics Inc.
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Cepheid Inc.
15.3. DiaSorin S.p.A.
15.4. Bio-Rad Laboratories Inc.
15.5. Thermo Fisher Scientific Inc.
15.6. Scienion GmbH
15.7. Grifols S.A.
15.8. Qiagen N.V.
15.9. Eiken Chemical Co. Ltd.
15.10. Laboratory Corporation of America Holdings

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER